Cohen & Steers, Inc. Peer Comparison
Metric | Value | Ranking | |||
---|---|---|---|---|---|
Market Cap | $4.2 Billion | 1/3 | CNS $4.2B |
FHI $3.1B |
DHIL $394.9M |
Gross Margin | 89% | 3/3 | DHIL 100% |
FHI 100% |
CNS 89% |
Profit Margin | 26% | 2/3 | DHIL 38% |
CNS 26% |
FHI 20% |
EBITDA margin | 43% | 1/3 | CNS 43% |
DHIL 26% |
FHI 26% |
Quarterly Revenue | $152.2 Million | 3/3 | DHIL $39.0B |
FHI $424.7M |
CNS $152.2M |
Quarterly Earnings | $39.7 Million | 3/3 | DHIL $14.6B |
FHI $83.9M |
CNS $39.7M |
Quarterly Free Cash Flow | $24.2 Million | 2/3 | DHIL $25.0B |
CNS $24.2M |
FHI -$0 |
Trailing 4 Quarters Revenue | $527.7 Million | 3/3 | DHIL $175.7B |
FHI $1.6B |
CNS $527.7M |
Trailing 4 Quarters Earnings | $135.3 Million | 3/3 | DHIL $39.0B |
FHI $424.7M |
CNS $152.2M |
Quarterly Earnings Growth | 23% | 2/3 | DHIL 226126% |
CNS 23% |
FHI 2% |
Annual Earnings Growth | 6% | 3/3 | DHIL 163438% |
FHI 100% |
CNS 6% |
Quarterly Revenue Growth | 34% | 2/3 | DHIL 109643% |
CNS 34% |
FHI 8% |
Annual Revenue Growth | 11% | 2/3 | DHIL 129470% |
CNS 11% |
FHI 2% |
Cash On Hand | $106.5 Million | 3/3 | DHIL $33.7B |
FHI $641.0M |
CNS $106.5M |
Short Term Debt | $0 | 2/3 | DHIL $6.4B |
CNS -$0 |
FHI -$0 |
Long Term Debt | $140.6 Million | 2/3 | FHI $348.1M |
CNS $140.6M |
DHIL $0 |
PE | 31.26 | 1/3 | CNS 31.26 |
FHI 11.58 |
DHIL 0.01 |
PS | 8.01 | 1/3 | CNS 8.01 |
FHI 1.90 |
DHIL 0.00 |
PB | 8.25 | 1/3 | CNS 8.25 |
FHI 2.15 |
DHIL 0.00 |
PC | 39.71 | 1/3 | CNS 39.71 |
FHI 4.85 |
DHIL 0.01 |
Liabilities to Equity | 0.44 | 2/3 | DHIL 0.45 |
CNS 0.44 |
FHI 0.44 |
ROA | 0.19 | 2/3 | DHIL 24% | CNS 19% | FHI 13% |
ROE | 0.28 | 2/3 | DHIL 34% |
CNS 28% |
FHI 19% |
Current Ratio | 3.38 | 1/3 | CNS 3.38 |
FHI 3.27 |
DHIL 3.24 |
Quick Ratio | 1.36 | 1/3 | CNS 31.26 |
FHI 11.58 |
DHIL 0.01 |
Long Term Debt to Equity | 0.29 | 1/3 | CNS} 0.29 |
FHI} 0.24 |
DHIL} 0.00 |
Debt to Equity | 0.29 | 1/3 | CNS 0.29 |
FHI 0.24 |
DHIL 0.04 |
Burn Rate | -3.13 | 2/3 | DHIL -2.58 |
CNS -3.13 |
FHI -9.17 |
Cash to Cap | 0.03 | 3/3 | DHIL 85.39 |
FHI 0.21 |
CNS 0.03 |
CCR | 0.61 | 2/3 | DHIL 1.71 |
CNS 0.61 |
FHI |
EV to EBITDA | 64.40 | 1/3 | CNS} 64.40 |
FHI} 25.49 |
DHIL} -2.64 |
EV to Revenue | 8.08 | 1/3 | CNS 8.08 |
FHI 1.72 |
DHIL -0.15 |